Marizyme, Inc. (MRZM)

Marizyme Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.18	0.65	0.23	0.21	0.2	-
Revenue Growth (YoY)	-68.96%	176.60%	11.04%	6.67%	-	-
Cost of Revenue	0.07	0.41	0.05	0.08	0.06	-
Gross Profit	0.12	0.24	0.18	0.13	0.14	-
Selling, General & Admin	10.38	16.54	6.43	6.33	2.83	1.06
Research & Development	1.37	2.18	3.98	1.68	0.69	-
Operating Expenses	12.48	20.08	13.15	8.95	5.94	1.06
Operating Income	-12.36	-19.84	-12.97	-8.82	-5.8	-1.06
Interest Expense	-31.99	-30.11	-2.78	-0.12	-0.05	-
Other Non Operating Income (Expenses)	25.82	4.98	1.6	-1.4	-	-
EBT Excluding Unusual Items	-18.53	-44.97	-14.15	-10.33	-5.85	-1.06
Asset Writedown	-14.24	-14.24	-24.35	-	-	-
Other Unusual Items	17.82	-6.13	0.34	-0.66	-	-
Pretax Income	-14.95	-65.35	-38.17	-11	-5.85	-1.06
Net Income	-14.95	-65.35	-38.17	-11	-5.85	-1.06
Net Income to Common	-14.95	-65.35	-38.17	-11	-5.85	-1.06
Shares Outstanding (Basic)	112	45	41	36	26	20
Shares Outstanding (Diluted)	112	45	41	36	26	20
Shares Change (YoY)	162.54%	11.65%	13.00%	36.66%	33.16%	196.88%
EPS (Basic)	-0.13	-1.44	-0.94	-0.31	-0.22	-0.05
EPS (Diluted)	-0.13	-1.44	-0.94	-0.31	-0.22	-0.05
Gross Margin	63.27%	36.99%	76.74%	61.79%	70.43%	-
Operating Margin	-6741.22%	-3072.44%	-5556.59%	-4195.09%	-2941.93%	-
Profit Margin	-8152.89%	-10118.60%	-16346.18%	-5230.16%	-2964.99%	-
EBITDA	-11.82	-19	-12.13	-8.78	-5.21	-
D&A For EBITDA	0.55	0.84	0.84	0.04	0.59	-
EBIT	-12.36	-19.84	-12.97	-8.82	-5.8	-1.06

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.